Adamas Pharmaceuticals' Series C Round

Adamas Pharmaceuticals raised a round of funding on July 25, 2006.

Adamas, formerly NeuroMolecular Pharmaceuticals, is a pharmaceutical company focused on developing small molecule, advantaged therapeutics to treat neurological and infectious diseases, including infl…

Articles about Adamas Pharmaceuticals' Series C Round: